Prelude Therapeutics

NASDAQ: PRLD · Real-Time Price · USD
0.98
-0.02 (-1.99%)
At close: Jun 05, 2025, 3:59 PM
0.92
-6.33%
After-hours: Jun 05, 2025, 06:40 PM EDT

Prelude Therapeutics Statistics

Share Statistics

Prelude Therapeutics has 56.46M shares outstanding. The number of shares has increased by 0.41% in one year.

56.46M
0.41%
0.22%
42.4%
n/a
9,725
5.39%

Short Selling Information

The latest short interest is 877.74K, so 1.55% of the outstanding shares have been sold short.

877.74K
1.55%
11.89%
7.9

Valuation Ratios

The PE ratio is -0.76 and the forward PE ratio is -0.86. Prelude Therapeutics's PEG ratio is 0.04.

-0.76
-0.86
13.75
0.5
0.73
-0.93
0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Prelude Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 5.3, with a Debt / Equity ratio of 0.14.

5.3
5.3
0.14
-0.13
-0.17
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$53,435.11
$-970,786.26
131
0.04
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -74.8% in the last 52 weeks. The beta is 1.24, so Prelude Therapeutics's price volatility has been higher than the market average.

1.24
-74.8%
0.83
1.53
59.63
180,446

Income Statement

In the last 12 months, Prelude Therapeutics had revenue of 7M and earned -127.17M in profits. Earnings per share was -1.68.

7M
5.23M
-139.71M
-127.17M
-139.71M
-139.71M
-1.68
Full Income Statement

Balance Sheet

The company has 12.47M in cash and 18.02M in debt, giving a net cash position of -5.55M.

12.47M
18.02M
-5.55M
-583.56M
141.26M
82.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -102.89M and capital expenditures -764K, giving a free cash flow of -103.65M.

-102.89M
-764K
-103.65M
-1.37
Full Cash Flow Statement

Margins

Gross margin is 74.69%, with operating and profit margins of -1995.91% and -1816.76%.

74.69%
-1995.91%
-1816.76%
-1816.76%
-1995.91%
-1995.91%
-1480.74%

Dividends & Yields

PRLD does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for PRLD is $4, which is 321.1% higher than the current price. The consensus rating is "Buy".

$4
321.1%
Buy
3
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-7.82
3